Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML
Jiaxiong Tan, Zhi Yu, Jingying Huang, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?
Alexandra Miggelbrink, Joshua Jackson, Selena Lorrey, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 21, pp. 5742-5752
Open Access | Times Cited: 171
TIM-3: An update on immunotherapy
Li‐Zhen Zhao, Shaoyun Cheng, Lin Fan, et al.
International Immunopharmacology (2021) Vol. 99, pp. 107933-107933
Closed Access | Times Cited: 137
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
Letong Cai, Yuchen Li, Jiaxiong Tan, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 119
Targeting macrophages in hematological malignancies: recent advances and future directions
Wei Li, Fang Wang, Rongqun Guo, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 96
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Sashi Kandel, Pratik Adhikary, Guangfu Li, et al.
Cancer Letters (2021) Vol. 510, pp. 67-78
Open Access | Times Cited: 96
Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment
Rongqun Guo, Mengdie Lü, Fujiao Cao, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 72
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
Mengjun Zhong, Rili Gao, Ruocong Zhao, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 40
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
Tatjana Sauerer, Giuliano Filippini Velázquez, Christoph Schmid
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 34
TIM-3 in Leukemia; Immune Response and Beyond
Mahnaz Rezaei, Jiaxiong Tan, Chengwu Zeng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 45
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells
Kyle A. Romine, Kevin MacPherson, Hyun-Jun Cho, et al.
Leukemia (2023) Vol. 37, Iss. 3, pp. 580-592
Open Access | Times Cited: 16
Expanded antigen-experienced CD160+CD8+effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia
Najmeh Bozorgmehr, Isobel Okoye, Olaide Oyegbami, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002189-e002189
Open Access | Times Cited: 35
PD-1 and TIGIT Are Highly Co-Expressed on CD8+ T Cells in AML Patient Bone Marrow
Ling Xu, Lian Liu, Danlin Yao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment
Ying Zhou, Muhammad Asad Farooq, Iqra Ajmal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115740-115740
Open Access | Times Cited: 15
A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
Ying Chen, Jishi Wang, Fengqi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Regulation of PD-1 in T cells for cancer immunotherapy
Xibao Yu, Rili Gao, Yangqiu Li, et al.
European Journal of Pharmacology (2020) Vol. 881, pp. 173240-173240
Closed Access | Times Cited: 34
One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia
Zhiding Wang, Jinghong Chen, Mengzhen Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Progress of research on PD-1/PD-L1 in leukemia
Huizhen Cao, Tianyu Wu, Xue Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
The role of CD4+ T cells in tumor and chronic viral immune responses
Luoyingzi Xie, Jingyi Fang, Juncheng Yu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 12
Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies
Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6356-6356
Open Access | Times Cited: 4
Characterization of alternative sPD-1 isoforms reveals that ECD sPD-1 signature predicts an efficient antitumor response
Ping Hou, Li Hu, Junrong Zhang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ γδ T Cells in AML Patients
Zhenyi Jin, Wanyi Ye, Tianbi Lan, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 28
Increased co-expression of ICOS and PD-1 predicts poor overall survival in patients with acute myeloid leukemia
Shiyi Pan, Qinghua Cai, Yiqiong Wei, et al.
Immunobiology (2024) Vol. 229, Iss. 3, pp. 152804-152804
Open Access | Times Cited: 3
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells
Giulia Corradi, Dorian Forte, Gianluca Cristiano, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment
Yasmina Serroukh, Josée Hébert, Lambert Busque, et al.
Blood Reviews (2022) Vol. 57, pp. 100991-100991
Open Access | Times Cited: 14
Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies
Luca Guarnera, Carlos Bravo‐Pérez, Valeria Visconte
Bioengineering (2023) Vol. 10, Iss. 10, pp. 1228-1228
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top